white paper download: validating the simoa technology!
Frontage is the first and only laboratory to validate Quanterix' Simoa HD1 Analyzer for performing immunoassays! Click here to download the White Paper.
a reputation for solving drug development challenges
Frontage helps organizations advance their early phase drug development efforts with extensive scientific and analytical services, including bioanalysis, preclinical, and Phase I-IIa studies and CMC product development. Our services and expert guidance span lead candidate identification in drug discovery through late stage clinical development. Biometrics capabilities support Phase I-IV clinical trials. CMC pharmaceutical development offerings range from organic synthesis to product commercialization support.
A deep understanding of drug development, combined with the skills and commitment to solve complex challenges reinforces our ability to deliver reliable data that provides informed decision making. We work with small and large molecules for novel biopharmaceuticals, as well as generic-equivalent and consumer products.
When you choose Frontage, we promise you a collaborative environment and a broad range of services and expertise delivered by skilled professionals. Our entire organization is geared toward flexibility and responsiveness.
Frontage is a Tigermed company. Please visit Tigermed's Website for more information!
Enroll in a Study | FAQ
> Frontage becomes 1st CRO to complete a GLP validation of the Simoa HD-1 Analyzer for Biomarker Analysis and announces Partnership with Quanterix! Read the Press Release here!
> Frontage's affiliate, Frontida, acquired Sun Pharmaceuticals' Philadelphia and Aurora facilities! Read the Press Release here!
> Frontage Bioanalytical Labs goes Paperless! Read the Press Release here!
> Frontage partners with Quanterix in Biomarker Assay Development. Read the Press Release here!
Join Frontage at these upcoming
Trade Shows & Events: